Literature DB >> 8440762

Pharmacokinetics of oral nifedipine in different populations.

G Castañeda-Hernández1, C Hoyo-Vadillo, J A Palma-Aguirre, F J Flores-Murrieta.   

Abstract

Nifedipine disposition varies among populations. Reports on oral nifedipine pharmacokinetics show that peak plasma levels and AUC values are higher in Mexican and Japanese than in European and North American subjects. Increased nifedipine bioavailability in the nonwhite populations is likely due to nutritional habits. Certain flavonoids that inhibit the first-pass metabolism of dihydropyridines are present in the diets of both Mexican and Japanese. Differences in phenotypes may play a role in interethnic variability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440762     DOI: 10.1002/j.1552-4604.1993.tb03934.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

Review 1.  Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.

Authors:  G R Wilkinson
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

Review 2.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

3.  Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.

Authors:  Xue-Ding Wang; Jia-Li Li; Qi-Biao Su; Su Guan; Jie Chen; Jun Du; Yu-Wen He; Jun Zeng; Jin-Xin Zhang; Xiao Chen; Min Huang; Shu-Feng Zhou
Journal:  Br J Clin Pharmacol       Date:  2008-12-01       Impact factor: 4.335

4.  Further evidence for interethnic differences in the oral pharmacokinetics of meloxicam.

Authors:  Miriam Del Carmen Carrasco-Portugal; José Carlos Aguilar-Carrasco; Miguel Luján; Gerardo Reyes-García; Roberto Medina-Santillán; Francisco J Flores-Murrieta
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.